ACRUX LIMITED - Announcements

10.0%

1.8¢

Market Cap $7.366M

Healthcare Drug Manufacturers - Specialty & Generic

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Announcements

Filter Results

All Price Sensitive Only

ACR	Receipt of second advance for FY25 R&D Tax Incentive	PRICE SENSITIVE	03/07/25	118.74KB	Share
ACR	Notification of cessation of securities - ACR		03/07/25	12.71KB	Share
ACR	Application for quotation of securities - ACR		03/07/25	14.29KB	Share
ACR	Change in substantial holding		30/06/25	319.37KB	Share
ACR	App 3Z, Kotsanis		02/06/25	272.13KB	Share
ACR	App 3X, Warmbrunn		02/06/25	226.16KB	Share
ACR	Appendix 3Y Brumley		23/05/25	212.24KB	Share
ACR	Application for quotation of securities - ACR		23/05/25	14.29KB	Share
ACR	Notification of cessation of securities - ACR		23/05/25	12.7KB	Share
ACR	Dapsone 7.5%, Gel launched in the United States	PRICE SENSITIVE	09/05/25	145.84KB	Share
ACR	Acrux CEO and Managing Director appointment	PRICE SENSITIVE	07/05/25	148.5KB	Share
ACR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	337.37KB	Share
ACR	Details of Share Registry address		09/04/25	115.43KB	Share
ACR	Appendix 3Y Dobinson		04/04/25	169.84KB	Share
ACR	Application for quotation of securities - ACR		04/04/25	15.51KB	Share
ACR	Acrux receives $1.73m advance on FY25 R&D Tax Incentive	PRICE SENSITIVE	03/04/25	117.26KB	Share
ACR	Attaching Options final application date 31 March 2025		07/03/25	119.83KB	Share
ACR	Notification of cessation of securities - ACR		06/03/25	12.7KB	Share
ACR	Appendix 3Y Dobinson		04/03/25	170.45KB	Share
ACR	Cleansing Notice		03/03/25	131.29KB	Share
ACR	Application for quotation of securities - ACR		03/03/25	15.41KB	Share
ACR	Investor Presentation February 2025	PRICE SENSITIVE	25/02/25	1.89MB	Share
ACR	Investor Webinar Announcement		25/02/25	96.64KB	Share
ACR	Appendix 4D and December 2024 Half Year Accounts	PRICE SENSITIVE	25/02/25	1MB	Share
ACR	Top20 quoted option holders and distribution schedule		19/02/25	130.7KB	Share
ACR	Appendix 3Y Oldham		19/02/25	213.28KB	Share
ACR	Appendix 3Y Kotsanis		19/02/25	191.39KB	Share
ACR	Appendix 3Y Brooke		19/02/25	197.66KB	Share
ACR	Appendix 3Y Brumley		19/02/25	212.47KB	Share
ACR	Application for quotation of securities - ACR		19/02/25	18.49KB	Share
ACR	Issue of Attaching Options initiated, extended Closing Date		19/02/25	117.08KB	Share
ACR	Notification regarding unquoted securities - ACR		18/02/25	15.66KB	Share
ACR	Application for quotation of securities - ACR		18/02/25	16.48KB	Share
ACR	Cleansing Notice - Reissued		13/02/25	131.02KB	Share
ACR	Application for quotation of securities - ACR		13/02/25	15.65KB	Share
ACR	Cleansing Notice		13/02/25	131.07KB	Share
ACR	Appendix 3Y x 4		13/02/25	314.78KB	Share
ACR	Acrux CEO announces plan to retire	PRICE SENSITIVE	07/02/25	96.14KB	Share
ACR	Results of EGM		03/02/25	184.19KB	Share
ACR	Monthly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	372.45KB	Share
ACR	Update - Proposed issue of securities - ACR		21/01/25	17.25KB	Share
ACR	Target Market Determination - Options		17/01/25	163.33KB	Share
ACR	Prospectus - Options		17/01/25	465.96KB	Share
ACR	Launch of 90 gram pack size of Dapsone 5%, Gel in US	PRICE SENSITIVE	16/01/25	111.26KB	Share
ACR	Notice of Extraordinary General Meeting/Proxy Form		03/01/25	421.46KB	Share
ACR	Cleansing Notice		23/12/24	131.65KB	Share
ACR	Application for quotation of securities - ACR		23/12/24	15.5KB	Share
ACR	Acrux raises $1.34 million from SPP	PRICE SENSITIVE	23/12/24	112.51KB	Share
ACR	Change in substantial holding		19/12/24	91.7KB	Share
ACR	Cleansing Notice		19/12/24	131.94KB	Share
ACR	Application for quotation of securities - ACR		19/12/24	15.67KB	Share
ACR	Investor Deck update, SPP Closes 18 December 2024, 5pm	PRICE SENSITIVE	17/12/24	1.94MB	Share
ACR	Investor Webinar, Tuesday 17 December 2024 4pm AEDT		16/12/24	121.92KB	Share
ACR	Commercialisation of Nitroglycerin Ointment	PRICE SENSITIVE	13/12/24	153.62KB	Share
ACR	Cleansing Notice		12/12/24	133.14KB	Share
ACR	Application for quotation of securities - ACR		12/12/24	15.61KB	Share
ACR	Notification of cessation of securities - ACR		12/12/24	12.64KB	Share
ACR	Appendix 3Y - Oldham		12/12/24	231.61KB	Share
ACR	Appendix 3Y - Dobinson		12/12/24	167.83KB	Share
ACR	Appendix 3Y Brooke		12/12/24	184.37KB	Share
ACR	Appendix 3Y - Brumley		12/12/24	231.2KB	Share
ACR	Cleansing Notice		12/12/24	131.07KB	Share
ACR	Application for quotation of securities - ACR		12/12/24	14.25KB	Share
ACR	Notification regarding unquoted securities - ACR		12/12/24	16.46KB	Share
ACR	Share Purchase Plan Offer Booklet	PRICE SENSITIVE	06/12/24	350.91KB	Share
ACR	Cleansing Notice		05/12/24	134.63KB	Share
ACR	Investor Presentation	PRICE SENSITIVE	05/12/24	2.05MB	Share
ACR	Proposed issue of securities - ACR		05/12/24	16.74KB	Share
ACR	Proposed issue of securities - ACR		05/12/24	17.55KB	Share
ACR	Proposed issue of securities - ACR		05/12/24	16.55KB	Share
ACR	Share Placement successfully concluded and SPP launched	PRICE SENSITIVE	05/12/24	168.21KB	Share
ACR	FDA Approval - Nitroglycerin Ointment	PRICE SENSITIVE	04/12/24	149.39KB	Share
ACR	Trading Halt	PRICE SENSITIVE	03/12/24	196.44KB	Share
ACR	Results of Meeting		21/11/24	182.45KB	Share
ACR	AGM Presentation	PRICE SENSITIVE	21/11/24	2.84MB	Share
ACR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/24	487.25KB	Share
ACR	Notice of Annual General Meeting/Proxy Form		15/10/24	660.25KB	Share
ACR	FY24 R&D Tax Incentive rebate received	PRICE SENSITIVE	02/10/24	116.83KB	Share
ACR	ASX Small and Mid Cap Conference presentation	PRICE SENSITIVE	24/09/24	1.57MB	Share
ACR	Investor Webinar Information - FY24 Results		29/08/24	95.8KB	Share
ACR	FY24 Full Year Results - Investor Presentation	PRICE SENSITIVE	29/08/24	1.02MB	Share
ACR	Appendix 4G and Corporate Governance Statement FY24		29/08/24	854.81KB	Share
ACR	Appendix 4E and FY24 Full Year Statutory Accounts	PRICE SENSITIVE	29/08/24	13.45MB	Share
ACR	FDA Approval received for Dapsone Gel, 7.5%	PRICE SENSITIVE	27/08/24	149.88KB	Share
ACR	Quarterly Activities Report and Appendix 4C - June 2024	PRICE SENSITIVE	26/07/24	481.67KB	Share
ACR	Acrux presentation to Bioshares, 18th Biotech Summit	PRICE SENSITIVE	15/07/24	1.44MB	Share
ACR	RDTI funding facility secured	PRICE SENSITIVE	28/06/24	117.41KB	Share
ACR	Acrux presentation at Hidden Gems in Lifesciences Forum	PRICE SENSITIVE	13/06/24	1.11MB	Share
ACR	Quarterly Activities and Appendix 4C, reissued		30/04/24	410.48KB	Share
ACR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	417.11KB	Share
ACR	Launch of Dapsone 5%, Gel in the United States	PRICE SENSITIVE	03/04/24	73.21KB	Share
ACR	Appendix 3Y Dobinson		05/03/24	167.86KB	Share
ACR	Appendix 3Y Brumley		05/03/24	211.46KB	Share
ACR	Application for quotation of securities - ACR		05/03/24	14.25KB	Share
ACR	Investor Presentation Half Year Accounts	PRICE SENSITIVE	27/02/24	699.42KB	Share
ACR	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	27/02/24	687.06KB	Share
ACR	Investor Webinar Details - Financial Results 1H FY24		23/02/24	122.61KB	Share
ACR	Application for quotation of securities - ACR		14/02/24	16.47KB	Share
ACR	Notification regarding unquoted securities - ACR		14/02/24	15.63KB	Share
ACR	Appendix 4C and Activities Statement	PRICE SENSITIVE	31/01/24	223.05KB	Share

ACR Receipt of second advance for FY25 R&D Tax Incentive
03/07/25	PRICE SENSITIVE	118.74KB	Share
ACR Notification of cessation of securities - ACR
03/07/25		12.71KB	Share
ACR Application for quotation of securities - ACR
03/07/25		14.29KB	Share
ACR Change in substantial holding
30/06/25		319.37KB	Share
ACR App 3Z, Kotsanis
02/06/25		272.13KB	Share
ACR App 3X, Warmbrunn
02/06/25		226.16KB	Share
ACR Appendix 3Y Brumley
23/05/25		212.24KB	Share
ACR Application for quotation of securities - ACR
23/05/25		14.29KB	Share
ACR Notification of cessation of securities - ACR
23/05/25		12.7KB	Share
ACR Dapsone 7.5%, Gel launched in the United States
09/05/25	PRICE SENSITIVE	145.84KB	Share
ACR Acrux CEO and Managing Director appointment
07/05/25	PRICE SENSITIVE	148.5KB	Share
ACR Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	337.37KB	Share
ACR Details of Share Registry address
09/04/25		115.43KB	Share
ACR Appendix 3Y Dobinson
04/04/25		169.84KB	Share
ACR Application for quotation of securities - ACR
04/04/25		15.51KB	Share
ACR Acrux receives $1.73m advance on FY25 R&D Tax Incentive
03/04/25	PRICE SENSITIVE	117.26KB	Share
ACR Attaching Options final application date 31 March 2025
07/03/25		119.83KB	Share
ACR Notification of cessation of securities - ACR
06/03/25		12.7KB	Share
ACR Appendix 3Y Dobinson
04/03/25		170.45KB	Share
ACR Cleansing Notice
03/03/25		131.29KB	Share
ACR Application for quotation of securities - ACR
03/03/25		15.41KB	Share
ACR Investor Presentation February 2025
25/02/25	PRICE SENSITIVE	1.89MB	Share
ACR Investor Webinar Announcement
25/02/25		96.64KB	Share
ACR Appendix 4D and December 2024 Half Year Accounts
25/02/25	PRICE SENSITIVE	1MB	Share
ACR Top20 quoted option holders and distribution schedule
19/02/25		130.7KB	Share
ACR Appendix 3Y Oldham
19/02/25		213.28KB	Share
ACR Appendix 3Y Kotsanis
19/02/25		191.39KB	Share
ACR Appendix 3Y Brooke
19/02/25		197.66KB	Share
ACR Appendix 3Y Brumley
19/02/25		212.47KB	Share
ACR Application for quotation of securities - ACR
19/02/25		18.49KB	Share
ACR Issue of Attaching Options initiated, extended Closing Date
19/02/25		117.08KB	Share
ACR Notification regarding unquoted securities - ACR
18/02/25		15.66KB	Share
ACR Application for quotation of securities - ACR
18/02/25		16.48KB	Share
ACR Cleansing Notice - Reissued
13/02/25		131.02KB	Share
ACR Application for quotation of securities - ACR
13/02/25		15.65KB	Share
ACR Cleansing Notice
13/02/25		131.07KB	Share
ACR Appendix 3Y x 4
13/02/25		314.78KB	Share
ACR Acrux CEO announces plan to retire
07/02/25	PRICE SENSITIVE	96.14KB	Share
ACR Results of EGM
03/02/25		184.19KB	Share
ACR Monthly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	372.45KB	Share
ACR Update - Proposed issue of securities - ACR
21/01/25		17.25KB	Share
ACR Target Market Determination - Options
17/01/25		163.33KB	Share
ACR Prospectus - Options
17/01/25		465.96KB	Share
ACR Launch of 90 gram pack size of Dapsone 5%, Gel in US
16/01/25	PRICE SENSITIVE	111.26KB	Share
ACR Notice of Extraordinary General Meeting/Proxy Form
03/01/25		421.46KB	Share
ACR Cleansing Notice
23/12/24		131.65KB	Share
ACR Application for quotation of securities - ACR
23/12/24		15.5KB	Share
ACR Acrux raises $1.34 million from SPP
23/12/24	PRICE SENSITIVE	112.51KB	Share
ACR Change in substantial holding
19/12/24		91.7KB	Share
ACR Cleansing Notice
19/12/24		131.94KB	Share
ACR Application for quotation of securities - ACR
19/12/24		15.67KB	Share
ACR Investor Deck update, SPP Closes 18 December 2024, 5pm
17/12/24	PRICE SENSITIVE	1.94MB	Share
ACR Investor Webinar, Tuesday 17 December 2024 4pm AEDT
16/12/24		121.92KB	Share
ACR Commercialisation of Nitroglycerin Ointment
13/12/24	PRICE SENSITIVE	153.62KB	Share
ACR Cleansing Notice
12/12/24		133.14KB	Share
ACR Application for quotation of securities - ACR
12/12/24		15.61KB	Share
ACR Notification of cessation of securities - ACR
12/12/24		12.64KB	Share
ACR Appendix 3Y - Oldham
12/12/24		231.61KB	Share
ACR Appendix 3Y - Dobinson
12/12/24		167.83KB	Share
ACR Appendix 3Y Brooke
12/12/24		184.37KB	Share
ACR Appendix 3Y - Brumley
12/12/24		231.2KB	Share
ACR Cleansing Notice
12/12/24		131.07KB	Share
ACR Application for quotation of securities - ACR
12/12/24		14.25KB	Share
ACR Notification regarding unquoted securities - ACR
12/12/24		16.46KB	Share
ACR Share Purchase Plan Offer Booklet
06/12/24	PRICE SENSITIVE	350.91KB	Share
ACR Cleansing Notice
05/12/24		134.63KB	Share
ACR Investor Presentation
05/12/24	PRICE SENSITIVE	2.05MB	Share
ACR Proposed issue of securities - ACR
05/12/24		16.74KB	Share
ACR Proposed issue of securities - ACR
05/12/24		17.55KB	Share
ACR Proposed issue of securities - ACR
05/12/24		16.55KB	Share
ACR Share Placement successfully concluded and SPP launched
05/12/24	PRICE SENSITIVE	168.21KB	Share
ACR FDA Approval - Nitroglycerin Ointment
04/12/24	PRICE SENSITIVE	149.39KB	Share
ACR Trading Halt
03/12/24	PRICE SENSITIVE	196.44KB	Share
ACR Results of Meeting
21/11/24		182.45KB	Share
ACR AGM Presentation
21/11/24	PRICE SENSITIVE	2.84MB	Share
ACR Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24	PRICE SENSITIVE	487.25KB	Share
ACR Notice of Annual General Meeting/Proxy Form
15/10/24		660.25KB	Share
ACR FY24 R&D Tax Incentive rebate received
02/10/24	PRICE SENSITIVE	116.83KB	Share
ACR ASX Small and Mid Cap Conference presentation
24/09/24	PRICE SENSITIVE	1.57MB	Share
ACR Investor Webinar Information - FY24 Results
29/08/24		95.8KB	Share
ACR FY24 Full Year Results - Investor Presentation
29/08/24	PRICE SENSITIVE	1.02MB	Share
ACR Appendix 4G and Corporate Governance Statement FY24
29/08/24		854.81KB	Share
ACR Appendix 4E and FY24 Full Year Statutory Accounts
29/08/24	PRICE SENSITIVE	13.45MB	Share
ACR FDA Approval received for Dapsone Gel, 7.5%
27/08/24	PRICE SENSITIVE	149.88KB	Share
ACR Quarterly Activities Report and Appendix 4C - June 2024
26/07/24	PRICE SENSITIVE	481.67KB	Share
ACR Acrux presentation to Bioshares, 18th Biotech Summit
15/07/24	PRICE SENSITIVE	1.44MB	Share
ACR RDTI funding facility secured
28/06/24	PRICE SENSITIVE	117.41KB	Share
ACR Acrux presentation at Hidden Gems in Lifesciences Forum
13/06/24	PRICE SENSITIVE	1.11MB	Share
ACR Quarterly Activities and Appendix 4C, reissued
30/04/24		410.48KB	Share
ACR Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	417.11KB	Share
ACR Launch of Dapsone 5%, Gel in the United States
03/04/24	PRICE SENSITIVE	73.21KB	Share
ACR Appendix 3Y Dobinson
05/03/24		167.86KB	Share
ACR Appendix 3Y Brumley
05/03/24		211.46KB	Share
ACR Application for quotation of securities - ACR
05/03/24		14.25KB	Share
ACR Investor Presentation Half Year Accounts
27/02/24	PRICE SENSITIVE	699.42KB	Share
ACR Appendix 4D and Half Year Accounts
27/02/24	PRICE SENSITIVE	687.06KB	Share
ACR Investor Webinar Details - Financial Results 1H FY24
23/02/24		122.61KB	Share
ACR Application for quotation of securities - ACR
14/02/24		16.47KB	Share
ACR Notification regarding unquoted securities - ACR
14/02/24		15.63KB	Share
ACR Appendix 4C and Activities Statement
31/01/24	PRICE SENSITIVE	223.05KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.8¢		Change -0.002(10.0%)		Mkt cap ! $7.366M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.8¢	$8.471K	470.6K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	370600	1

View Market Depth

No.	Vol.	Price($)
4	691823	0.017
10	960173	0.016
5	1311882	0.015
2	140000	0.014
3	486850	0.013

Price($)	Vol.	No.
0.020	370600	1
0.021	111922	1
0.022	100000	1
0.023	381179	1
0.024	201073	3

Last trade - 13.32pm 25/07/2025 (20 minute delay)

ACR (ASX) Chart

ACRUX LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories